ArticleProceedings of the National Academy of Sciences of the United States of America2015

Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.

Mohammad T Mazhab-Jafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.